ZA200606971B - Benzopyran compound - Google Patents

Benzopyran compound

Info

Publication number
ZA200606971B
ZA200606971B ZA200606971A ZA200606971A ZA200606971B ZA 200606971 B ZA200606971 B ZA 200606971B ZA 200606971 A ZA200606971 A ZA 200606971A ZA 200606971 A ZA200606971 A ZA 200606971A ZA 200606971 B ZA200606971 B ZA 200606971B
Authority
ZA
South Africa
Prior art keywords
benzopyran compound
benzopyran
compound
Prior art date
Application number
ZA200606971A
Other languages
English (en)
Inventor
Tsukagoshi Toru
Nagatsuka Takayuki
Matsuda Tomoyuki
Hashimoto Norio
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of ZA200606971B publication Critical patent/ZA200606971B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
ZA200606971A 2004-02-25 2005-02-25 Benzopyran compound ZA200606971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004048842 2004-02-25

Publications (1)

Publication Number Publication Date
ZA200606971B true ZA200606971B (en) 2009-01-28

Family

ID=34879527

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606971A ZA200606971B (en) 2004-02-25 2005-02-25 Benzopyran compound

Country Status (21)

Country Link
US (1) US7781483B2 (xx)
EP (1) EP1718629B1 (xx)
JP (1) JP4798378B2 (xx)
KR (1) KR101010676B1 (xx)
CN (1) CN1980910B (xx)
AU (1) AU2005214276B8 (xx)
BR (1) BRPI0506609A (xx)
CA (1) CA2557395C (xx)
CZ (1) CZ2006517A3 (xx)
EG (1) EG25913A (xx)
ES (1) ES2401587T3 (xx)
HK (1) HK1097831A1 (xx)
IL (1) IL177673A (xx)
NO (1) NO20064336L (xx)
NZ (1) NZ549494A (xx)
RU (1) RU2366658C2 (xx)
SK (1) SK288112B6 (xx)
TW (1) TWI346112B (xx)
UA (1) UA90856C2 (xx)
WO (1) WO2005080368A2 (xx)
ZA (1) ZA200606971B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2003135A4 (en) 2006-03-10 2011-03-02 Nissan Chemical Ind Ltd PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMENE OXIDE COMPOUND
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound
JP2014533258A (ja) 2011-11-15 2014-12-11 ゼンション・リミテッドXention Limited カリウムチャネル阻害剤としてのチエノ[2,3−c]ピラゾールの使用
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
TWI633095B (zh) * 2013-03-08 2018-08-21 賽諾菲公司 經取代-6-基氧基-環烷類及其作為醫藥品之用途
CN113543849A (zh) * 2018-12-28 2021-10-22 国立大学法人大阪大学 遗传性缓慢性心律失常治疗药

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
DE3368057D1 (en) * 1982-05-21 1987-01-15 Beecham Group Plc Pharmaceutically active aminobenzopyrans
GB8521857D0 (en) * 1985-09-03 1985-10-09 Beecham Group Plc Active compounds
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
JPH09235227A (ja) 1995-12-25 1997-09-09 Nissan Chem Ind Ltd 心不全治療薬
NZ333870A (en) 1996-07-26 2000-08-25 Nissan Chemical Ind Ltd 4-amino substituted chroman derivatives
DE69921815T2 (de) 1998-06-03 2005-11-10 Nissan Chemical Industries, Ltd. Indanderivate
WO2000012492A1 (en) 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
WO2000058300A1 (fr) 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Derives du chroman
ATE311378T1 (de) 1999-09-17 2005-12-15 Nissan Chemical Ind Ltd Benzopyran derivate
AU7319800A (en) 1999-09-24 2001-04-24 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
EP1218367A1 (en) 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
CN1198804C (zh) * 2000-03-16 2005-04-27 三菱制药株式会社 酰胺化合物及其用途
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
ATE305930T1 (de) 2001-06-25 2005-10-15 Nissan Chemical Ind Ltd Substituierte benzopyran derivate gegen arrhythmie
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use

Also Published As

Publication number Publication date
AU2005214276A1 (en) 2005-09-01
SK50712006A3 (sk) 2007-07-06
RU2006133931A (ru) 2008-03-27
EG25913A (en) 2012-10-10
CN1980910B (zh) 2012-06-13
CZ2006517A3 (cs) 2006-11-15
CA2557395A1 (en) 2005-09-01
CN1980910A (zh) 2007-06-13
TW200533660A (en) 2005-10-16
UA90856C2 (xx) 2010-06-10
KR20070032300A (ko) 2007-03-21
BRPI0506609A (pt) 2007-05-02
NO20064336L (no) 2006-09-25
SK288112B6 (sk) 2013-08-02
US20070299130A1 (en) 2007-12-27
IL177673A (en) 2013-03-24
JP2007523885A (ja) 2007-08-23
HK1097831A1 (en) 2007-07-06
KR101010676B1 (ko) 2011-01-24
NZ549494A (en) 2010-06-25
TWI346112B (en) 2011-08-01
WO2005080368A2 (en) 2005-09-01
WO2005080368A3 (en) 2005-11-10
IL177673A0 (en) 2006-12-31
AU2005214276B2 (en) 2010-05-20
AU2005214276B8 (en) 2010-06-10
CA2557395C (en) 2011-01-18
EP1718629B1 (en) 2012-12-26
JP4798378B2 (ja) 2011-10-19
ES2401587T3 (es) 2013-04-22
US7781483B2 (en) 2010-08-24
RU2366658C2 (ru) 2009-09-10
EP1718629A2 (en) 2006-11-08

Similar Documents

Publication Publication Date Title
IL181732A0 (en) 2-morpholino-4-pyrimidone compound
EP1717239A4 (en) SUBSTITUTED SYM TRIINDOLE
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
EP1732560A4 (en) SUBSTITUTED CINNOLINE-4-YLAMINE
GB0415663D0 (en) Compound
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
TWI346112B (en) Benzopyran compound
GB0408771D0 (en) Compound
GB0421106D0 (en) Compound
GB0408777D0 (en) Compounds
GB0411562D0 (en) Compound
GB0425969D0 (en) Compound
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
GB0426061D0 (en) Chroman compounds
GB0403593D0 (en) Compounds
GB0428295D0 (en) Compound
GB0403595D0 (en) Compounds
GB0413768D0 (en) Novel compound
GB0413758D0 (en) Novel compound
GB0413766D0 (en) Novel compound
GB0413365D0 (en) Novel compound
GB0413769D0 (en) Novel compound
GB0413764D0 (en) Novel compound
GB0412550D0 (en) Novel compound